Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedAdded 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' as related topics on the study page.SummaryDifference0.1%

- Check8 days agoChange DetectedThe study locations section was expanded to include additional sites across the United States, Canada, and Australia, and several specific location entries were removed.SummaryDifference1.0%

- Check16 days agoChange DetectedNon-alcoholic fatty liver disease and MedlinePlus Genetics were added under related topics. These changes provide supplementary metadata for discovery and indexing rather than modifying study content or patient-facing details.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the related topic labels 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe Publications section was updated to indicate that publications are automatically filled from PubMed and may not be about the study, replacing the previous wording. The page revision was updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRemoved the government funding operating-status notice from the page; no changes to study details, inclusion/exclusion criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.